Clinical Study Results
Where can I learn more about this study?
You can find more information about this study on the websites listed below. If
more information about the study results is available, it can also be found here.
• www.clinicaltrials.gov. Once you are on the website, type “NCT03596177”
into the search box, and click “Search”.
• http://www.clinicaltrialsregister.eu. Once you are on the website, click “Home
and Search”, then type “2018-001220-19” in the search box, and click
“Search”.
• www.AstraZenecaClinicalTrials.com. Once you are on the website, type
“D5670C00021” into the search box, and click “Find a Study”.
Full Trial Title: An Exploratory Phase 2a, Randomised, Double-blind, Placebo
controlled Study to Evaluate the Effect of MEDI0382 on Energy Balance in
Overweight and Obese Subjects with Type 2 Diabetes Mellitus
AstraZeneca Protocol Number: D5670C00021
MedImmune, a wholly owned subsidiary of AstraZeneca, sponsored this study
and has its headquarters at 1 Medimmune Way, Gaithersburg, MD 20878.
The phone number for the AstraZeneca Information Center is
+1-877-240-9479.
Thank you!
Clinical study participants belong to a large community of people who take part in
clinical research around the world. They help researchers answer important health
questions and find medical treatments for patients.
The Center for Information & Study on Clinical Research
Participation (CISCRP) is a non-profit organization focused
on educating and informing the public about clinical research
participation. CISCRP is not involved in recruiting participants for
clinical studies, nor is it involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 1100 • Boston, MA 02109
1-877-MED-HERO • www.ciscrp.org
Version 1.0 2020_11_12 12